Nipro Medical Corporation, a wholly-owned subsidiary of Japan-based Nipro Corporation,  plans to invest $398 million in constructing a medical device facility in North Carolina. This strategic investment underscores Nipro’s commitment to support the growing demand for advanced medical devices such as dialysis products, infusion pumps, and critical care equipment in the US market, says GlobalData, a leading data and analytics company.

GlobalData forecasts the medical device market to grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2032 to reach $800.32 billion in 2032. Significant advancements in medical device manufacturing technologies are expected to drive efficiency and innovation in the sector.

Graysen Vigneux, Medical Analyst at GlobalData, comments: “The establishment of Nipro’s new facility in North Carolina is a testament to the increasing demand for advanced medical devices. This facility will not only boost Nipro’s production capabilities but also enhance the availability of latest medical devices in the US market.”

Nipro’s new facility will focus on the production of various medical devices, including dialysis products, infusion pumps, and other critical care equipment. The facility aims to meet the growing demand for high-quality medical devices and support the healthcare infrastructure in the US.

Vigneux concludes: “Nipro’s investment in North Carolina reflects the company’s dedication to innovation and strategic approach to expanding its footprint in the US. This move is expected to create job opportunities and contribute to the economic growth of the region.

“In addition to the new facility, Nipro continues to explore further advancements in medical technology, including next-generation dialysis machines and innovative infusion systems. These initiatives highlight Nipro’s ongoing efforts to improve patient outcomes and solidify its position as a leader in the medical device industry.”